Member Profile: Pancreatic Cancer UK

,

The vision of Pancreatic Cancer UK is that everyone with pancreatic cancer survives to live long and well.

Each year, Pancreatic Cancer UK helps thousands of people across the UK by providing information and support, funding world class research and campaigning to improve the quality of care for people with pancreatic cancer. Its vision is that everyone with pancreatic cancer survives to live long and well.

Pancreatic Cancer UK is the longest running pancreatic cancer charity in the UK. Founded in 2003 by Susan Ballard a few years after she lost her husband to pancreatic cancer, it was registered as a charity in 2006.

Pancreatic Cancer UK provides expert, personalized support and information through its website, a range of publications and via its Support Line – the only Support Line dedicated solely to pancreatic cancer in the UK.

The organization funds innovative research across the UK to find the breakthroughs that will change how we understand, diagnose and treat pancreatic cancer.  A number of projects are well-underway, and the organization also recently announced the awarding of its largest-ever research grant, the Pancreatic Cancer UK Grand Challenge. The recipients are Professor Nick Lemoine, a leading pancreatic cancer expert, and a team of researchers at Barts Cancer Institute and King’s College London. Together they are focusing on an extremely promising area of research called immunotherapy, building on 20 years of research in the field.

Pancreatic Cancer UK.

In addition, Pancreatic Cancer UK campaigns for change; for better care, treatment and research; and for pancreatic cancer to have the recognition it needs. They do this through major campaigns such as Pancreatic Cancer Awareness Month, and they Demand Better for patients and their loved ones on a daily basis. For instance, by working with the pancreatic cancer community, their Promoting Innovative Practice initiative seeks to identify new developments in care and treatment that can potentially improve patients’ outcomes. They will highlight and share these examples among health practitioners and call for their adoption across the NHS in the UK.

The WPCC was established to bring about transformative change for those affected by pancreatic cancer. This is very much aligned with Pancreatic Cancer UK’s mission, so they are delighted to be a part of that change both in the UK and on a global scale.